E LEE BENDEKGEY Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for E LEE BENDEKGEY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of E LEE BENDEKGEY. E LEE BENDEKGEY is Senior VP and General Counsel in ARCA biopharma, Inc. ($ABIO) and Sr VP CFO & General Counsel in ARCA biopharma, Inc. ($ABIO) and Chief Financial Officer in Invitae Corp ($NVTA) and Chief Operating Officer in Invitae Corp ($NVTA).
Latest Insider Trading Transactions of E LEE BENDEKGEY
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Option Exercise | M | 2.82 | 27,500 | 77,550 | 0 | |
| Jul 15 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 34.96 | 7,730 | 270,262 | 218,311 | 226 K to 218.3 K (-3.42 %) |
| Jul 15 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Option Exercise | M | 2.82 | 27,500 | 77,550 | 0 | |
| Jul 15 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 34.31 | 12,445 | 427,025 | 226,041 | 238.5 K to 226 K (-5.22 %) |
| Jul 15 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 34.96 | 7,730 | 270,262 | 218,311 | 226 K to 218.3 K (-3.42 %) |
| Jul 15 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 33.07 | 7,325 | 242,222 | 238,486 | 245.8 K to 238.5 K (-2.98 %) |
| Jul 15 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 34.31 | 12,445 | 427,025 | 226,041 | 238.5 K to 226 K (-5.22 %) |
| Jul 15 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Buy | M | 2.82 | 27,500 | 77,550 | 245,811 | 218.3 K to 245.8 K (+12.60 %) |
| Jul 15 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 33.07 | 7,325 | 242,222 | 238,486 | 245.8 K to 238.5 K (-2.98 %) |
| Jul 15 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Buy | M | 2.82 | 27,500 | 77,550 | 245,811 | 218.3 K to 245.8 K (+12.60 %) |
| Jun 16 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Option Exercise | A | 16.17 | 19,600 | 316,932 | 19,600 | |
| Jun 16 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Grant | A | 0.00 | 59,150 | 0 | 218,311 | 159.2 K to 218.3 K (+37.16 %) |
| Jun 16 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Option Exercise | A | 16.17 | 19,600 | 316,932 | 19,600 | |
| Jun 16 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Grant | A | 0.00 | 59,150 | 0 | 218,311 | 159.2 K to 218.3 K (+37.16 %) |
| May 22 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 16.70 | 9,348 | 156,119 | 159,161 | 168.5 K to 159.2 K (-5.55 %) |
| May 14 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 18.53 | 4,965 | 92,022 | 168,509 | 173.5 K to 168.5 K (-2.86 %) |
| May 14 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 17.96 | 13,700 | 246,057 | 173,474 | 187.2 K to 173.5 K (-7.32 %) |
| Mar 16 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 11.79 | 11,056 | 130,350 | 187,174 | 198.2 K to 187.2 K (-5.58 %) |
| Mar 16 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Grant | A | 0.00 | 91,733 | 0 | 198,230 | 106.5 K to 198.2 K (+86.14 %) |
| Feb 28 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Option Exercise | M | 2.82 | 27,500 | 77,550 | 27,500 | |
| Feb 28 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Option Exercise | M | 10.23 | 4,375 | 44,756 | 65,625 | |
| Feb 28 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Option Exercise | M | 9.90 | 20,755 | 205,475 | 49,245 | |
| Feb 28 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Option Exercise | M | 8.70 | 25,000 | 217,500 | 0 | |
| Feb 28 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Option Exercise | M | 3.42 | 8,333 | 28,499 | 0 | |
| Feb 28 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 21.35 | 28,357 | 605,416 | 106,497 | 134.9 K to 106.5 K (-21.03 %) |
| Feb 28 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 20.58 | 91,432 | 1,881,671 | 134,854 | 226.3 K to 134.9 K (-40.41 %) |
| Feb 28 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Buy | M | 2.82 | 27,500 | 77,550 | 226,286 | 198.8 K to 226.3 K (+13.83 %) |
| Feb 28 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Buy | M | 10.23 | 4,375 | 44,756 | 198,786 | 194.4 K to 198.8 K (+2.25 %) |
| Feb 28 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Buy | M | 9.90 | 20,755 | 205,475 | 194,411 | 173.7 K to 194.4 K (+11.95 %) |
| Feb 28 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Buy | M | 8.70 | 25,000 | 217,500 | 173,656 | 148.7 K to 173.7 K (+16.82 %) |
| Feb 28 2020 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Buy | M | 3.42 | 8,333 | 28,499 | 148,656 | 140.3 K to 148.7 K (+5.94 %) |
| Aug 21 2019 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 25.29 | 21,265 | 537,883 | 140,323 | 161.6 K to 140.3 K (-13.16 %) |
| May 22 2019 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 18.21 | 6,851 | 124,757 | 161,588 | 168.4 K to 161.6 K (-4.07 %) |
| May 15 2019 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 18.78 | 4,657 | 87,439 | 168,439 | 173.1 K to 168.4 K (-2.69 %) |
| Feb 27 2019 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 19.62 | 4,650 | 91,213 | 173,096 | 177.7 K to 173.1 K (-2.62 %) |
| Nov 16 2018 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Payment of Exercise | F | 12.23 | 4,650 | 56,870 | 177,746 | 182.4 K to 177.7 K (-2.55 %) |
| Jun 25 2018 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Grant | A | 0.00 | 130,000 | 0 | 182,396 | 52.4 K to 182.4 K (+248.11 %) |
| May 16 2018 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Operating Off ... | Sell | S | 6.96 | 6,388 | 44,460 | 52,396 | 58.8 K to 52.4 K (-10.87 %) |
| Feb 15 2017 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Financial Off ... | Sell | S | 9.59 | 2,098 | 20,120 | 58,784 | 60.9 K to 58.8 K (-3.45 %) |
| Feb 15 2017 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Financial Off ... | Grant | A | 0.00 | 5,000 | 0 | 60,882 | 55.9 K to 60.9 K (+8.95 %) |
| Feb 07 2017 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Financial Off ... | Grant | A | 0.00 | 55,882 | 0 | 55,882 | 0 to 55.9 K |
| Apr 04 2016 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Financial Off ... | Option Exercise | A | 10.23 | 70,000 | 716,100 | 70,000 | |
| Aug 06 2015 | NVTA | Invitae Corp | BENDEKGEY E LEE | Chief Financial Off ... | Option Exercise | A | 9.91 | 70,000 | 693,700 | 70,000 | |
| Aug 03 2005 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Sr VP CFO & General ... | Option Exercise | A | 9.16 | 190 | 1,740 | 190 | |
| Aug 03 2005 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Sr VP CFO & General ... | Option Exercise | A | 9.16 | 149,810 | 1,372,260 | 149,810 | |
| Jan 11 2005 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Sr VP CFO & General ... | Option Exercise | A | 9.83 | 10,833 | 106,488 | 10,833 | |
| Jan 11 2005 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Sr VP CFO & General ... | Option Exercise | A | 9.83 | 39,167 | 385,012 | 39,167 | |
| Jul 13 2004 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Senior VP and Gener ... | Option Exercise | A | 8.41 | 47,560 | 399,980 | 47,560 | |
| Jul 13 2004 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Senior VP and Gener ... | Option Exercise | A | 8.41 | 77,440 | 651,270 | 77,440 |
Page: 1